Affordable Access

Publisher Website

Diagnostic Bronchoalveolar Lavage in Immunosuppressed Patients With New Pulmonary Infiltrates

Authors
Journal
Mayo Clinic Proceedings
0025-6196
Publisher
Elsevier
Volume
67
Issue
3
Identifiers
DOI: 10.1016/s0025-6196(12)60108-6
Keywords
  • Editorials
Disciplines
  • Medicine

Abstract

The diagnostic assessment of new pulmonary infiltrates in immunosuppressed patients remains a major problem for the clinician (Table 1). The number of patients with severe immunosuppression at risk for a pulmonary complication continues to increase as more patients receive cytotoxic chemotherapy, undergo organ transplantation, or become infected with the human immunodeficiency virus. The challenge to the clinician is to be aware of the changing patient populations and to recognize the relative risk of which complication is associated with a specific clinical manifestation. Valid diagnostic approaches developed in the 1960s and 1970s may have less applicability as newer technologies become available and provide for a less invasive and more rapid diagnosis (Table 2).

There are no comments yet on this publication. Be the first to share your thoughts.